Company Filing History:
Years Active: 1992-1996
Title: Takashi Narui: Innovator in Pharmaceutical Technology
Introduction
Takashi Narui is a prominent inventor based in Sakura, Japan. He has made significant contributions to the field of pharmaceutical technology, holding a total of 4 patents. His work focuses on developing innovative drug delivery systems that enhance therapeutic efficacy and safety.
Latest Patents
One of Narui's latest inventions is a sustained-release suppository. This preparation is characterized by comprising an acidic drug or a salt that can be absorbed through rectal administration, along with an acidic compound or a pH buffering agent. The sustained-release suppository is designed to avoid rapid increases in blood concentration immediately after administration, thereby maintaining its action for an extended period. This innovation not only enhances safety but also improves therapeutic outcomes.
Another notable patent involves corticosteroid-containing ointments. These ointments consist of 0.05-1 wt. % of deprodone propionate and 89-99.95 wt. % of a base made from white petroleum and a liquid hydrocarbon. Additionally, they may contain 1-10 wt. % of a polyhydric alcohol. This formulation aims to provide effective topical treatment while ensuring patient comfort.
Career Highlights
Narui is associated with Ss Pharmaceutical Co., Ltd., where he continues to push the boundaries of pharmaceutical innovation. His work has been instrumental in developing formulations that address specific medical needs, showcasing his commitment to improving patient care.
Collaborations
Throughout his career, Narui has collaborated with notable colleagues, including Akira Iwasa and Tetsuo Kaneko. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical research.
Conclusion
Takashi Narui's contributions to pharmaceutical technology exemplify the impact of innovative thinking in medicine. His patents reflect a dedication to enhancing drug delivery systems, ultimately benefiting patients worldwide.